446 related articles for article (PubMed ID: 17973308)
1. Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.
Caldwell JC; Keshava N; Evans MV
Environ Mol Mutagen; 2008 Mar; 49(2):142-54. PubMed ID: 17973308
[TBL] [Abstract][Full Text] [Related]
2. Toxicological review of male reproductive effects and trichloroethylene exposure: assessing the relevance to human male reproductive health.
Lamb JC; Hentz KL
Reprod Toxicol; 2006 Nov; 22(4):557-63. PubMed ID: 16938429
[TBL] [Abstract][Full Text] [Related]
3. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.
Caldwell JC; Keshava N
Environ Health Perspect; 2006 Sep; 114(9):1457-63. PubMed ID: 16966105
[TBL] [Abstract][Full Text] [Related]
4. A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.
Lewandowski TA; Rhomberg LR
Regul Toxicol Pharmacol; 2005 Feb; 41(1):39-54. PubMed ID: 15649826
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats.
Anand SS; Mumtaz MM; Mehendale HM
Arch Toxicol; 2005 Nov; 79(11):671-82. PubMed ID: 15940471
[TBL] [Abstract][Full Text] [Related]
6. Trichloroethylene and cancer: epidemiologic evidence.
Scott CS; Cogliano VJ
Environ Health Perspect; 2000 May; 108 Suppl 2():159-60. PubMed ID: 10807549
[TBL] [Abstract][Full Text] [Related]
7. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Bogen KT; Gold LS
Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
[TBL] [Abstract][Full Text] [Related]
8. Trichloroethylene risk assessment: a review and commentary.
Jollow DJ; Bruckner JV; McMillan DC; Fisher JW; Hoel DG; Mohr LC
Crit Rev Toxicol; 2009; 39(9):782-97. PubMed ID: 19852561
[TBL] [Abstract][Full Text] [Related]
9. Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and Andersen.
Caldwell JC; Evans MV; Marcus AH; Scott CS; Chiu WA; Okino MS; Preuss PW
Crit Rev Toxicol; 2006 Mar; 36(3):291-4; discussion 295-8. PubMed ID: 16686425
[TBL] [Abstract][Full Text] [Related]
10. Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment.
Lock EA; Reed CJ
Toxicol Sci; 2006 Jun; 91(2):313-31. PubMed ID: 16421178
[TBL] [Abstract][Full Text] [Related]
11. Trichloroethylene and ocular malformations: analysis of extant literature.
Williams AL; DeSesso JM
Int J Toxicol; 2008; 27(1):81-95. PubMed ID: 18293215
[TBL] [Abstract][Full Text] [Related]
12. [Renal cell carcinoma and exposure to trichloroethylene: are the French limits of occupational exposure relevant?].
Charbotel B; Fevotte J; Martin JL; Bergeret A
Rev Epidemiol Sante Publique; 2009 Feb; 57(1):41-7. PubMed ID: 19155150
[TBL] [Abstract][Full Text] [Related]
13. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
14. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Fisher JW; Mahle D; Abbas R
Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
[TBL] [Abstract][Full Text] [Related]
15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
16. Trichloroethylene. II. Mechanism of carcinogenicity of trichloroethylene.
Motohashi N; Nagashima H; Molnár J
In Vivo; 1999; 13(3):215-9. PubMed ID: 10459494
[TBL] [Abstract][Full Text] [Related]
17. Trichloroethylene-contaminated drinking water and congenital heart defects: a critical analysis of the literature.
Watson RE; Jacobson CF; Williams AL; Howard WB; DeSesso JM
Reprod Toxicol; 2006 Feb; 21(2):117-47. PubMed ID: 16181768
[TBL] [Abstract][Full Text] [Related]
18. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
Clewell HJ; Andersen ME
Crit Rev Toxicol; 2004; 34(5):385-445. PubMed ID: 15560567
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.
Yoo HS; Bradford BU; Kosyk O; Shymonyak S; Uehara T; Collins LB; Bodnar WM; Ball LM; Gold A; Rusyn I
J Toxicol Environ Health A; 2015; 78(1):15-31. PubMed ID: 25424544
[TBL] [Abstract][Full Text] [Related]
20. Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rat.
Barton HA; Creech JR; Godin CS; Randall GM; Seckel CS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):237-47. PubMed ID: 7871537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
